RxSight, Inc. (RXST) earnings
RXST earnings moved a median of -1.52% by the close. Quarterly and annual RXST reports and results, each read against the price at its own news timestamp. Back to the RXST overview →
22 measured RXST earnings events.
Where these RXST earnings landedvs 21 measured RXST earnings reactions
| Middle 50% of RXST earnings reactions | -6.60% to +1.33% |
|---|---|
| Median reaction (to close) | -1.52% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 RXST earnings events with a measured close landed between -6.60% and +1.33%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3 | Press release | — | — | |
| Form 10-Q RxSight, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +1.33% | |
| RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook | Press release | +0.00% | +1.33% | |
| Form 10-Q RxSight, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.82% | -6.60% | |
| RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook | Press release | +2.82% | -6.60% | |
| RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6 | Press release | -0.75% | -1.91% | |
| Form 10-K RxSight, Inc. For: Dec 31 | SEC filing · Form 10-K | +8.02% | +4.07% | |
| Form 10-Q RxSight, Inc. For: Sep 30 | SEC filing · Form 10-Q | -5.40% | -13.03% | |
| RxSight, Inc. Reports Third Quarter 2025 Financial Results | Press release | -5.40% | -13.03% | |
| RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025 | Press release | +0.23% | -1.52% | |
| Form 10-Q RxSight, Inc. For: Jun 30 | SEC filing · Form 10-Q | -8.72% | -3.49% | |
| RxSight, Inc. Reports Second Quarter 2025 Financial Results | Press release | -8.72% | -3.49% | |
| RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | -1.88% | -0.38% | |
| RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance | Press release | +3.44% | +23.83% | |
| Form 10-Q RxSight, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.99% | -14.15% | |
| RxSight, Inc. Reports First Quarter 2025 Financial Results | Press release | -3.99% | -14.15% | |
| RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 | Press release | +0.14% | +0.93% | |
| RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | Press release | -2.50% | +1.31% | |
| Form 10-K RxSight, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.49% | +5.58% | |
| Form 10-Q RxSight, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.32% | +2.08% | |
| RxSight, Inc. Reports Third Quarter 2024 Financial Results | Press release | -4.32% | +2.08% | |
| Form 10-Q RxSight, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.82% | -5.08% |
Keep exploring
More RXST: analyst actions → · SEC filings → · RXST overview →